PECAM1 and myeloid sarcoma: CD31+ endothelial MVs, identified in plasma samples by FACS, have been associated to clinical and neuroradiological exacerbation of MS, while CD51+ endothelial MVs have been found elevated in both relapsing and remitting MS patients as compared to controls (65).